Mushtaq A Ansari Selected Research

N- (3- propylcarbamoyloxirane- 2- carbonyl)- isoleucyl- proline

1/2022

Cathepsin B inhibitor alleviates Th1, Th17, and Th22 transcription factor signaling dysregulation in experimental autoimmune encephalomyelitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mushtaq A Ansari Research Topics

Disease

20	Autistic Disorder (Autism) 01/2022 - 01/2017
9	Inflammation (Inflammations) 03/2021 - 09/2015
6	Neuroinflammatory Diseases 01/2020 - 10/2017
4	Experimental Arthritis 03/2021 - 12/2019
4	Cardiotoxicity 07/2019 - 04/2013
4	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2017 - 09/2015
3	Rheumatoid Arthritis 01/2020 - 12/2019
3	Neoplasms (Cancer) 01/2019 - 06/2016
3	Nervous System Diseases (Neurological Disorders) 12/2018 - 10/2017
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 01/2017
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 01/2022
2	Autism Spectrum Disorder 12/2020 - 06/2020
2	Carcinogenesis 01/2020 - 01/2019
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2020 - 01/2019
2	Asthma (Bronchial Asthma) 01/2017 - 05/2016
1	Memory Disorders (Memory Loss) 01/2022
1	Demyelinating Diseases (Demyelinating Disease) 01/2022
1	Communicable Diseases (Infectious Diseases) 03/2021
1	Arthritis (Polyarthritis) 03/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Chromosomal Instability (Chromosome Stability) 01/2021
1	Cardiomegaly (Heart Hypertrophy) 01/2021
1	Multiple Sclerosis 01/2021
1	Encephalomyelitis (Myeloencephalitis) 01/2021
1	Long Term Adverse Effects 07/2020
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Colitis 01/2020
1	Infections 01/2019
1	Leukemia 11/2017
1	Hematologic Neoplasms (Hematological Malignancy) 11/2017

Drug/Important Bio-Agent (IBA)

11	CytokinesIBA 12/2020 - 09/2015
7	Transcription Factors (Transcription Factor)IBA 01/2022 - 09/2015
7	Proteins (Proteins, Gene)FDA Link 07/2020 - 04/2013
6	Chemokine ReceptorsIBA 01/2022 - 02/2018
5	Interleukin-17 (Interleukin 17)IBA 03/2021 - 05/2016
5	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2018 - 01/2017
4	AntioxidantsIBA 01/2021 - 05/2017
4	Tyrosine Kinase InhibitorsIBA 01/2020 - 06/2016
4	Imiquimod (Aldara)FDA LinkGeneric 05/2017 - 09/2015
3	Interleukin-9 (Interleukin 9)IBA 03/2021 - 10/2017
3	Messenger RNA (mRNA)IBA 01/2021 - 04/2013
3	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 01/2019
3	N- (1- (3- (4- ethoxyphenyl)- 4- oxo- 3,4- dihydropyrido(2,3- d)pyrimidin- 2- yl)ethyl)- N- pyridin- 3- ylmethyl- 2- (4- trifluoromethoxyphenyl)acetamideIBA 07/2020 - 12/2019
3	Peroxidase (Myeloperoxidase)IBA 01/2017 - 09/2015
2	Therapeutic UsesIBA 02/2021 - 10/2019
2	5-aminoisoquinolinoneIBA 02/2021 - 01/2020
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 07/2020 - 11/2015
2	GlucocorticoidsIBA 07/2020 - 11/2015
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 06/2020 - 01/2017
2	AG 127 (AG 126)IBA 01/2020 - 01/2018
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 01/2018
2	TyrphostinsIBA 01/2020 - 01/2018
2	LipidsIBA 07/2019 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 07/2019 - 01/2017
2	ResveratrolIBA 01/2018 - 04/2013
2	Lipid PeroxidesIBA 01/2017 - 05/2016
2	EnzymesIBA 06/2016 - 04/2013
1	Cathepsin BIBA 01/2022
1	UCB 35625IBA 01/2022
1	methylmercuric chlorideIBA 01/2022
1	N- (3- propylcarbamoyloxirane- 2- carbonyl)- isoleucyl- prolineIBA 01/2022
1	SB-332235IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Maraviroc FDA Link 03/2021
1	Chemokine CCL5IBA 03/2021
1	CC ChemokinesIBA 03/2021
1	Interleukin-10 (Interleukin 10)IBA 02/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2021
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 01/2021
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2021
1	Acetylcarnitine (Alcar)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	InterleukinsIBA 12/2020
1	3-aminobenzamideIBA 12/2020
1	CXCR3 ReceptorsIBA 01/2020
1	Histone Deacetylase InhibitorsIBA 01/2020
1	Vorinostat FDA Link 01/2020
1	3-phenyl-4,5-dihydro-5-isoxazole acetic acidIBA 11/2019
1	NSC 74859IBA 10/2019
1	Phosphodiesterase 4 InhibitorsIBA 07/2019
1	Glutathione Transferase (Glutathione S-Transferase)IBA 07/2019
1	CadmiumIBA 07/2019
1	RoflumilastIBA 07/2019
1	Interleukin-16 (Interleukin 16)IBA 02/2019
1	PanobinostatIBA 01/2019
1	AntigensIBA 12/2018
1	HLA-DR Antigens (HLA-DR)IBA 12/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2018
1	(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA 11/2018
1	PPAR deltaIBA 11/2018
1	CCR ReceptorsIBA 02/2018
1	CXC ChemokinesIBA 01/2018
1	Neuroprotective AgentsIBA 01/2018
1	Dexrazoxane (Zinecard)FDA LinkGeneric 11/2017
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 11/2017
1	AnthracyclinesIBA 11/2017

Therapy/Procedure

7	Therapeutics 01/2022 - 09/2015
1	Intraperitoneal Injections 01/2018